.RESEARCH STUDY EMPHASIZE.06 August 2024.
A large randomized regulated trial with cisgender ladies highlights the difficulties of fidelity to a daily oral preexposure treatment regiment as well as illustrates that twice-yearly injection of lenacapavir may keep helpful HIV deterrence degrees over 6 months.